Yun-Han Hong

Can Immune-related adverse events serve as clinical biomarkers of PD-1/PD-L1 inhibitor efficacy in Pan-Cancer Patients?

Ziqi Ye, Jie Chen, Yanfang Zhang, 2022, International immunopharmacology.

A Mechanistic Study of the Intestinal Absorption of Cryptotanshinone, the Major Active Constituent of Salvia miltiorrhiza

M. Huang, Shufeng Zhou, S. Chan, 2006, Journal of Pharmacology and Experimental Therapeutics.

Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C9*72-*75 in the Chinese Han population

Jie Yang, D. Dai, Quan Zhou, 2022, Frontiers in Pharmacology.

Induction of propranolol metabolism by Ginkgo biloba extract EGb 761 in rats.

Shufeng Zhou, E. Chan, W. Duan, 2006, Current drug metabolism.

Evaluation of commonly used cardiovascular drugs in inhibiting vonoprazan metabolism in vitro and in vivo

Shuanghu Wang, D. Dai, Peiwu Geng, 2022, Frontiers in Pharmacology.

Assessments of CYP‑inhibition‑based drug–drug interaction between vonoprazan and poziotinib in vitro and in vivo

D. Dai, Shuang-hu Wang, P. Geng, 2023, Pharmaceutical biology.

Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects

Lili Zou, D. Dai, Jiefu Yang, 2023, Frontiers in Endocrinology.